Research programme: nitric oxide synthase inhibitors - Beyond Air
Latest Information Update: 30 Jun 2023
Price :
$50 *
At a glance
- Originator Hebrew University of Jerusalem
- Developer Beyond Air
- Class Neuroprotectants; Small molecules
- Mechanism of Action Nitric oxide synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autistic disorder; Neurological disorders